LISTE DES PUBLICATIONS (depuis 2011)/ LIST OF

LISTE DES PUBLICATIONS (depuis 2011)/ LIST OF

LISTE DES PUBLICATIONS (depuis 2011)/ LIST OF PUBLICATIONS (from 2011)
Equipe 2/Team 2: Complications vasculaires du diabète/Vascular complications of diabetes
Responsable/ Head: Ronan ROUSSEL
2015
Desposito D, Potier L, Chollet C, Gobeil F, Jr., Roussel R, Alhenc-Gelas F, Bouby N,
Waeckel L (2015) Kinin receptor agonism restores hindlimb postischemic neovascularization
capacity in diabetic mice. J Pharmacol Exp Ther 352 (2): 218-226
Taveau C, Chollet C, Waeckel L, Desposito D, Bichet DG, Arthus MF, Magnan C, Philippe
E, Paradis V, Foufelle F, Hainault I, Enhorning S, Velho G, Roussel R, Bankir L, Melander
O, Bouby N (2015) Vasopressin and hydration play a major role in the development of
glucose intolerance and hepatic steatosis in obese rats. Diabetologia, (DOI) 10.1007/s00125015-3496-9
Youcef G, E. Belaidi E, Waeckel L, Fazal L, Clemessy M, Vincent MP, Zadigue G, Richer
C, Alhenc-Gelas F, Ovize M, Pizard A (2015) Tissue kallikrein is required for the
cardioprotective effect of cyclosporin A in myocardial ischemia in the mouse. Biochem.
Pharmacol, doi: 10.1016/j.bcp.2015.01.007.
Mohammedi K, Bellili-Muñoz N, Marklund SL, Driss F, Le Nagard H, Patente TA,
Fumeron1 F, Roussel R, Hadjadj S, Marre M, Velho G (2015) Plasma extracellular
superoxide dismutase concentration, allelic variations in the SOD3 gene and risk of
myocardial infarction and all-cause mortality in people with type 1 and type 2 diabetes.
Cardiovascular Diabetology, accepted
Fumeron F, Bard J-M, Vergès B, Paillard F, Lecerf J-M (2015) Phytostérols : un point sur les
recommandations de l’ANSES. OCL -Oilseeds and fats, Crops and Lipids, accepted
2014
Wood AR et al (2014) Defining the role of common variation in the genomic and biological
architecture of adult human height. Nat Genet 46 (11): 1173-1186
Karakachoff M, Duforet-Frebourg N, Simonet F, Le Scouarnec S, Pellen N, Lecointe S,
Charpentier E, Gros F, Cauchi S, Froguel P, Copin N; the D.E.S.I.R. Study Group, Le
Tourneau T, Probst V, Le Marec H, Molinaro S, Balkau B, Redon R, Schott JJ, Blum MG,
Dina C; the D E S I R Study Group (2014). Eur J Hum Genet. 2014 3. doi:
10.1038/ejhg.2014.175.
Voisin V, Decleves AE, Hubert V, Colombaro V, Giordano L, Habsch I, Bouby N, Nonclercq
D, Caron N (2014) Protection of Wistar-Furth rats against postischaemic acute renal injury:
Role for nitric oxide and thromboxane? Clin Exp Pharmacol Physiol 41 (11): 911-920
Verges B, Fumeron F (2014) Potential risks associated with increased plasma plant-sterol
levels. Diabetes Metab Dec 9. pii:S1262-3636(14)00177-3. doi: 10.1016/j.diabet.2014.11.003.
Lecerf J-M, Bard J-M, Girardet J-P, Fumeron F, Paillard F, Vergès B (2014) Phytostérols,
phytostanols, et risque cardiovasculaire [Phytosterols, phytostanols, and cardiovascular risk].
Médecine des Maladies Métaboliques; 8 : 483-488
Saulnier PJ, Gand E, Ragot S, Ducrocq G, Halimi JM, Hulin-Delmotte C, Llaty P, Montaigne
D, Rigalleau V, Roussel R, Velho G, Sosner P, Zaoui P, Hadjadj S, Group SS (2014)
Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2
diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort. Diabetes Care
37 (5): 1425-1431
Roussel R, Fezeu L, Marre M, Velho G, Fumeron F, Jungers P, Lantieri O, Balkau B, Bouby
N, Bankir L, Bichet DG (2014) Comparison between copeptin and vasopressin in a
population from the community and in people with chronic kidney disease. J Clin Endocrinol
Metab 99 (12): 4656-4663
Raccah D, Lin J, Wang E, Germe M, Perfetti R, Bonadonna RC, de Pablos-Velasco P,
Roussel R, Rosenstock J (2014) Once-daily prandial lixisenatide versus once-daily rapidacting insulin in patients with type 2 diabetes mellitus insufficiently controlled with basal
insulin: analysis of data from five randomized, controlled trials. J Diabetes Complications 28
(1): 40-44
Potier L, Waeckel L, Fumeron F, Bodin S, Fysekidis M, Chollet C, Bellili N, Bonnet F, Gusto
G, Velho G, Marre M, Alhenc-Gelas F, Roussel R, Bouby N, Group DS (2014) Tissue
kallikrein deficiency, insulin resistance, and diabetes in mouse and man. J Endocrinol 221 (2):
297-308
Potier L, Roussel R, Labreuche J, Marre M, Cacoub P, Rother J, Wilson PW, Goto S, Bhatt
DL, Steg PG, for the RI (2014) Interaction between diabetes and a high ankle-brachial index
on mortality risk. Eur J Prev Cardiol
Plischke M, Kohl M, Bankir L, Shayganfar S, Handisurya A, Heinze G, Haas M (2014) Urine
osmolarity and risk of dialysis initiation in a chronic kidney disease cohort--a possible
titration target? PLoS One 9 (3): e93226
Mohammedi K, Bellili-Munoz N, Driss F, Roussel R, Seta N, Fumeron F, Hadjadj S, Marre
M, Velho G (2014) Manganese superoxide dismutase (SOD2) polymorphisms, plasma
advanced oxidation protein products (AOPP) concentration and risk of kidney complications
in subjects with type 1 diabetes. PLoS One 9 (5): e96916
Mohammedi K, Abi Khalil C, Olivier S, Benabad I, Roussel R, Marre M (2014)
Paraneoplastic hypoglycemia in a patient with a malignant solitary fibrous tumor. Endocrinol
Diabetes Metab Case Rep 2014 140026
Messadi E, Aloui Z, Belaidi E, Vincent MP, Couture-Lepetit E, Waeckel L, Decorps J, Bouby
N, Gasmi A, Karoui H, Ovize M, Alhenc-Gelas F, Richer C (2014) Cardioprotective effect of
VEGF and venom VEGF-like protein in acute myocardial ischemia in mice: effect on
mitochondrial function. J Cardiovasc Pharmacol 63 (3): 274-281
Johnson RJ, Rodriguez-Iturbe B, Roncal-Jimenez C, Lanaspa MA, Ishimoto T, Nakagawa T,
Correa-Rotter R, Wesseling C, Bankir L, Sanchez-Lozada LG (2014) Hyperosmolarity drives
hypertension and CKD--water and salt revisited. Nat Rev Nephrol 10 (7): 415-420
Hus-Citharel A, Bodineau L, Frugiere A, Joubert F, Bouby N, Llorens-Cortes C (2014)
Apelin counteracts vasopressin-induced water reabsorption via cross talk between apelin and
vasopressin receptor signaling pathways in the rat collecting duct. Endocrinology 155 (11):
4483-4493
Girolami JP, Blaes N, Bouby N, Alhenc-Gelas F (2014) Genetic manipulation and genetic
variation of the kallikrein-kinin system: impact on cardiovascular and renal diseases. Prog
Drug Res 69: 145-196
Germain M, Pezzolesi MG, Sandholm N, McKnight AJ, Susztak K, Lajer M, Forsblom C,
Marre M, Parving HH, Rossing P, Toppila I, Skupien J, Roussel R, Ko YA, Ledo N,
Folkersen L, Civelek M, Maxwell AP, Tregouet DA, Groop PH, Tarnow L, Hadjadj S (2014)
SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genomewide association study in patients with type 1 diabetes. Diabetologia Dec 6.
Foucan L, Maimaitiming S, Larifla L, Hedreville S, Deloumeaux J, Joannes MO, BlanchetDeverly A, Velayoudom-Cephise FL, Aubert R, Salamon R, Donnet JP, Fumeron F (2014)
Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic
patients. J Diabetes Investig 5 (2): 192-198
Fezeu L, Bankir L, Hansel B, Guerrot D (2014) Differential circadian pattern of water and Na
excretion rates in the metabolic syndrome. Chronobiol Int 31 (7): 861-867
Feldman L, Tubach F, Juliard JM, Himbert D, Ducrocq G, Sorbets E, Triantafyllou K, Kerner
A, Abergel H, Huisse MG, Roussel R, Esposito-Farese M, Steg PG, Ajzenberg N (2014)
Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel
platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent
placement. Am Heart J 168 (6): 940-947
de Hauteclocque A, Ragot S, Slaoui Y, Gand E, Miot A, Sosner P, Halimi JM, Zaoui P,
Rigalleau V, Roussel R, Saulnier PJ, Hadjadj Samy S, group SS (2014) The influence of sex
on renal function decline in people with Type 2 diabetes. Diabet Med 31 (9): 1121-1128
Calvez T, Chambost H, Claeyssens-Donadel S, d'Oiron R, Goulet V, Guillet B, Heritier V,
Milien V, Rothschild C, Roussel-Robert V, Vinciguerra C, Goudemand J, FranceCoag N
(2014) Recombinant factor VIII products and inhibitor development in previously untreated
boys with severe hemophilia A. Blood 124 (23): 3398-3408
Bouby N, Clark WF, Roussel R, Taveau C, Wang CJ (2014) Hydration and kidney health.
Obes Facts 7 Suppl 2 19-32
Bankir L (2014) Active urea transport in lower vertebrates and mammals. Subcell Biochem
73 193-226
2013
Waeckel L, Potier L, Richer C, Roussel R, Bouby N, Alhenc-Gelas F (2013) Pathophysiology
of genetic deficiency in tissue kallikrein activity in mouse and man. Thromb Haemost 110
(3): 476-483
Velho G, Bouby N, Hadjadj S, Matallah N, Mohammedi K, Fumeron F, Potier L, BelliliMunoz N, Taveau C, Alhenc-Gelas F, Bankir L, Marre M, Roussel R (2013) Plasma copeptin
and renal outcomes in patients with type 2 diabetes and albuminuria. Diabetes Care 36 (11):
3639-3645
Stenvinkel P, Frobert O, Anderstam B, Palm F, Eriksson M, Bragfors-Helin AC, Qureshi AR,
Larsson T, Friebe A, Zedrosser A, Josefsson J, Svensson M, Sahdo B, Bankir L, Johnson RJ
(2013) Metabolic changes in summer active and anuric hibernating free-ranging brown bears
(Ursus arctos). PLoS One 8 (9): e72934
Samara A, Herbeth B, Ndiaye NC, Fumeron F, Billod S, Siest G, Visvikis-Siest S (2013)
Dairy product consumption, calcium intakes, and metabolic syndrome-related factors over 5
years in the STANISLAS study. Nutrition 29 (3): 519-524
Saddi-Rosa P, Oliveira C, Crispim F, Giuffrida FM, de Lima V, Vieira J, Doria A, Velho G,
Reis A (2013) Association of circulating levels of nicotinamide phosphoribosyltransferase
(NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with
coronary artery disease in diabetic and non-diabetic subjects. Cardiovasc Diabetol 12 119
Sacre K, Dehoux M, Chauveheid MP, Chauchard M, Lidove O, Roussel R, Papo T (2013)
Pituitary-adrenal function after prolonged glucocorticoid therapy for systemic inflammatory
disorders: an observational study. J Clin Endocrinol Metab 98 (8): 3199-3205
Roussel R, Hadjadj S, Pasquet B, Wilson PW, Smith SC, Jr., Goto S, Tubach F, Marre M,
Porath A, Krempf M, Bhatt DL, Steg PG (2013) Thiazolidinedione use is not associated with
worse cardiovascular outcomes: a study in 28,332 high risk patients with diabetes in routine
clinical practice: brief title: thiazolidinedione use and mortality. Int J Cardiol 167 (4): 13801384
Reutens AT, Bonnet F, Lantieri O, Roussel R, Balkau B, Epidemiological Study on the
Insulin Resistance Syndrome Study G (2013) The association between cystatin C and incident
type 2 diabetes is related to central adiposity. Nephrol Dial Transplant 28 (7): 1820-1829
Potier L, Waeckel L, Vincent MP, Chollet C, Gobeil F, Jr., Marre M, Bruneval P, Richer C,
Roussel R, Alhenc-Gelas F, Bouby N (2013) Selective kinin receptor agonists as
cardioprotective agents in myocardial ischemia and diabetes. J Pharmacol Exp Ther 346 (1):
23-30
Potier L, Waeckel L, Richer C, Roussel R, Bouby N, Alhenc-Gelas F (2013) Tissue
kallikrein, blood pressure regulation, and hypertension: insight from genetic kallikrein
deficiency. Biol Chem 394 (3): 329-333
Monteiro MB, Patente TA, Mohammedi K, Queiroz MS, Azevedo MJ, Canani LH, Parisi
MC, Marre M, Velho G, Correa-Giannella ML (2013) Sex-specific associations of variants in
regulatory regions of NADPH oxidase-2 (CYBB) and glutathione peroxidase 4 (GPX4) genes
with kidney disease in type 1 diabetes. Free Radic Res 47 (10): 804-810
Mohammedi K, Patente TA, Bellili-Munoz N, Driss F, Monteiro MB, Roussel R, Pavin EJ,
Seta N, Fumeron F, Azevedo MJ, Canani LH, Hadjadj S, Marre M, Correa-Giannella ML,
Velho G (2013) Catalase activity, allelic variations in the catalase gene and risk of kidney
complications in patients with type 1 diabetes. Diabetologia 56 (12): 2733-2742
Lemes VA, Neves AL, Guazzelli IC, Frazzatto E, Nicolau C, Correa-Giannella ML, Velho G,
Villares SM (2013) Angiotensin converting enzyme insertion/deletion polymorphism is
associated with increased adiposity and blood pressure in obese children and adolescents.
Gene 532 (2): 197-202
Layton AT, Bankir L (2013) Impacts of Active Urea Secretion into Pars Recta on Urine
Concentration and Urea Excretion Rate. Physiol Rep 1 (3):
Lamri A, Poli A, Emery N, Bellili N, Velho G, Lantieri O, Balkau B, Marre M, Fumeron F
(2013) The lactase persistence genotype is associated with body mass index and dairy
consumption in the D.E.S.I.R. study. Metabolism 62 (9): 1323-1329
Hansel B, Roussel R, Diguet V, Deplaude A, Chapman MJ, Bruckert E (2013) Relationships
between consumption of alcoholic beverages and healthy foods: the French supermarket
cohort of 196,000 subjects. Eur J Prev Cardiol
Girolami JP, Alhenc-Gelas F (2013) Highlight: kinin 2012 in Paris. Biol Chem 394 (3): 317
Fumeron F (2013) Genetics of the human obesities Obésité; 8: 22-33
Fumeron F (2013) Genetics of the human obesities In “Physiology and Pathophysiology of
adipose tissue” Bastard JP, Fève B editors, Springer-Verlag France, pp351-372
Ferrarezi DA, Bellili-Munoz N, Dubois-Laforgue D, Cheurfa N, Lamri A, Reis AF, Le
Feuvre C, Roussel R, Fumeron F, Timsit J, Marre M, Velho G (2013) Allelic variations of the
vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease
in type 2 diabetics: the DIABHYCAR prospective study. Diabetes Metab 39 (3): 263-270
Enhorning S, Bankir L, Bouby N, Struck J, Hedblad B, Persson M, Morgenthaler NG, Nilsson
PM, Melander O (2013) Copeptin, a marker of vasopressin, in abdominal obesity, diabetes
and microalbuminuria: the prospective Malmo Diet and Cancer Study cardiovascular cohort.
Int J Obes (Lond) 37 (4): 598-603
Dong Z, Ran J, Zhou H, Chen J, Lei T, Wang W, Sun Y, Lin G, Bankir L, Yang B (2013)
Urea transporter UT-B deletion induces DNA damage and apoptosis in mouse bladder
urothelium. PLoS One 8 (10): e76952
Brioude F, Bouligand J, Francou B, Fagart J, Roussel R, Viengchareun S, Combettes L,
Brailly-Tabard S, Lombes M, Young J, Guiochon-Mantel A (2013) Two families with
normosmic congenital hypogonadotropic hypogonadism and biallelic mutations in KISS1R
(KISS1 receptor): clinical evaluation and molecular characterization of a novel mutation.
PLoS One 8 (1): e53896
Bottolo L, Chadeau-Hyam M, Hastie DI, Zeller T, Liquet B, Newcombe P, Yengo L, Wild
PS, Schillert A, Ziegler A, Nielsen SF, Butterworth AS, Ho WK, Castagne R, Munzel T,
Tregouet D, Falchi M, Cambien F, Nordestgaard BG, Fumeron F, Tybjaerg-Hansen A,
Froguel P, Danesh J, Petretto E, Blankenberg S, Tiret L, Richardson S (2013) GUESS-ing
polygenic associations with multiple phenotypes using a GPU-based evolutionary stochastic
search algorithm. PLoS Genet 9 (8): e1003657
Bonnet F, Roussel R, Natali A, Cauchi S, Petrie J, Laville M, Yengo L, Froguel P, Lange C,
Lantieri O, Marre M, Balkau B, Ferrannini E, Desir, Groups RS (2013) Parental history of
type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident
hypertension. Data from the DESIR and RISC cohorts. Diabetologia 56 (11): 2414-2423
Bonnefond A, Saulnier PJ, Stathopoulou MG, Grarup N, Ndiaye NC, Roussel R, Nezhad MA,
Dechaume A, Lantieri O, Hercberg S, Lauritzen T, Balkau B, El-Sayed Moustafa JS, Hansen
T, Pedersen O, Froguel P, Charpentier G, Marre M, Hadjadj S, Visvikis-Siest S (2013) What
is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and
to microvascular complications? PLoS One 8 (2): e55921
Bankir L, Bouby N, Ritz E (2013) Vasopressin: a novel target for the prevention and
retardation of kidney disease? Nat Rev Nephrol 9 (4): 223-239
2012
Waeckel L, Potier L, Chollet C, Taveau C, Bruneval P, Roussel R, Alhenc-Gelas F, Bouby N
(2012) Antihypertensive role of tissue kallikrein in hyperaldosteronism in the mouse.
Endocrinology 153 (8): 3886-3896
Verges B, Avignon A, Bonnet F, Catargi B, Cattan S, Cosson E, Ducrocq G, Elbaz M,
Fredenrich A, Gourdy P, Henry P, Lairez O, Leguerrier AM, Monpere C, Moulin P, VergesPatois B, Roussel R, Steg G, Valensi P, Diabetes, Cardiovascular Disease study group of the
Societe francophone du d, Societe francaise de c (2012) Consensus statement on the care of
the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary
syndrome. Arch Cardiovasc Dis 105 (4): 239-253
Sandholm N, et al (2012) New susceptibility loci associated with kidney disease in type 1
diabetes. PLoS Genet 8 (9): e1002921
Pasquier C, Andreutti C, Bertrand E, Bostan A, Bourlet T, Molina I, Grossman Z, Halfon P,
Leruez-Ville M, Luneborg-Nielsen M, Mar C, Marcelin AG, Roussel-Ronserail C, Schmitt
MP, Tabrizi S, Vourliotis M, Bujan L (2012) Multicenter assessment of HIV-1 RNA
quantitation in semen in the CREAThE network. J Med Virol 84 (2): 183-187
Oliveira CS, Saddi-Rosa P, Crispim F, Canani LH, Gerchman F, Giuffrida FM, Vieira JG,
Velho G, Reis AF (2012) Association of ADIPOQ variants, total and high molecular weight
adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian
subjects. J Diabetes Complications 26 (2): 94-98
Neves AL, Mohammedi K, Emery N, Roussel R, Fumeron F, Marre M, Velho G (2012)
Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular
morbidity and mortality in type 2 diabetic subjects. Mol Genet Metab 106 (3): 359-365
Montaigne D, Bailloeuil O, Hulin-Delmotte C, Edme JL, Sosner P, Miot A, Ragot S, Saulnier
PJ, Dupuy O, Gourdy P, Lecomte P, Guerci B, Dardari D, Roussel R, Neviere R, Lacroix D,
Hadjadj S, Diab2Nephrogene, groups Ss (2012) Renal complications correlate with electrical
atrial vulnerability hallmarks in type 2 diabetic patients. Int J Cardiol 159 (1): 63-66
Larifla L, Maimaitiming S, Velayoudom-Cephise FL, Ferdinand S, Blanchet-Deverly A,
Benabdallah S, Donnet JP, Atallah A, Roussel R, Foucan L (2012) Association of 2238T>C
polymorphism of the atrial natriuretic peptide gene with coronary artery disease in AfroCaribbeans with type 2 diabetes. Am J Hypertens 25 (5): 524-527
Lamri A, Abi Khalil C, Jaziri R, Velho G, Lantieri O, Vol S, Froguel P, Balkau B, Marre M,
Fumeron F (2012) Dietary fat intake and polymorphisms at the PPARG locus modulate BMI
and type 2 diabetes risk in the D.E.S.I.R. prospective study. Int J Obes (Lond) 36 (2): 218-224
Fumeron F, Vari IS, Grandchamp B, Balkau B (2012) Comment on: Park et al. Association of
serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5year follow-up study. Diabetes Care 2012;35:2521-2526. Diabetes Care 35 (12): e92
Fumeron F. Génétique des obésités humaines (2012) In « Physiologie et Physiopathologie du
tissu adipeux » Bastard JP, Fève B coordonnateurs, Springer-Verlag Paris, pp359-380
Ferrarezi DA, Bellili-Munoz N, Nicolau C, Cheurfa N, Guazzelli IC, Frazzatto E, Velho G,
Villares SM (2012) Allelic variations in the vitamin D receptor gene, insulin secretion and
parents' heights are independently associated with height in obese children and adolescents.
Metabolism 61 (10): 1413-1421
Decleves AE, Caron N, Voisin V, Legrand A, Bouby N, Kultti A, Tammi MI, Flamion B
(2012) Synthesis and fragmentation of hyaluronan in renal ischaemia. Nephrol Dial
Transplant 27 (10): 3771-3781
Coussement J, Danguy C, Zouaoui-Boudjeltia K, Defrance P, Bankir L, Biston P, Piagnerelli
M (2012) Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with
urea in critically ill patients. Am J Nephrol 35 (3): 265-270
Bonnefond A, Clement N, Fawcett K, Yengo L, Vaillant E, Guillaume JL, Dechaume A,
Payne F, Roussel R, Czernichow S, Hercberg S, Hadjadj S, Balkau B, Marre M, Lantieri O,
Langenberg C, Bouatia-Naji N, Meta-Analysis of G, Insulin-Related Traits C, Charpentier G,
Vaxillaire M, Rocheleau G, Wareham NJ, Sladek R, McCarthy MI, Dina C, Barroso I,
Jockers R, Froguel P (2012) Rare MTNR1B variants impairing melatonin receptor 1B
function contribute to type 2 diabetes. Nat Genet 44 (3): 297-301
Beltrand J, Caquard M, Arnoux JB, Laborde K, Velho G, Verkarre V, Rahier J, Brunelle F,
Nihoul-Fekete C, Saudubray JM, Robert JJ, de Lonlay P (2012) Glucose metabolism in 105
children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care
35 (2): 198-203
Bankir L, Yang B (2012) New insights into urea and glucose handling by the kidney, and the
urine concentrating mechanism. Kidney Int 81 (12): 1179-1198
Bankir L, Bichet DG (2012) Polycystic kidney disease: An early urea-selective urineconcentrating defect in ADPKD. Nat Rev Nephrol 8 (8): 437-439
Abi Khalil C, Roussel R, Mohammedi K, Danchin N, Marre M (2012) Cause-specific
mortality in diabetes: recent changes in trend mortality. Eur J Prev Cardiol 19 (3): 374-381
2011
Spinetti G, Fortunato O, Cordella D, Portararo P, Krankel N, Katare R, Sala-Newby GB,
Richer C, Vincent MP, Alhenc-Gelas F, Tonolo G, Cherchi S, Emanueli C, Madeddu P
(2011) Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells.
Circ Res 108 (3): 284-293
Saulnier PJ, Roussel R, Halimi JM, Lebrec J, Dardari D, Maimaitiming S, Guilloteau G,
Prugnard X, Marechaud R, Ragot S, Marre M, Hadjadj S, Surdiagene DN, groups Ds (2011)
Impact of natriuretic peptide clearance receptor (NPR3) gene variants on blood pressure in
type 2 diabetes. Diabetes Care 34 (5): 1199-1204
Roussel R, Fezeu L, Bouby N, Balkau B, Lantieri O, Alhenc-Gelas F, Marre M, Bankir L,
Group DESIRS (2011) Low water intake and risk for new-onset hyperglycemia. Diabetes
Care 34 (12): 2551-2554
Reis AF, Kannengiesser C, Jennane F, Manna TD, Cheurfa N, Oudin C, Savoldelli RD,
Oliveira C, Grandchamp B, Kok F, Velho G (2011) Two novel mutations in the EIF2AK3
gene in children with Wolcott-Rallison syndrome. Pediatr Diabetes 12 (3 Pt 1): 187-191
Potier L, Abi Khalil C, Mohammedi K, Roussel R (2011) Use and utility of ankle brachial
index in patients with diabetes. Eur J Vasc Endovasc Surg 41 (1): 110-116
Mohammedi K, Roussel R, El Dbouni O, Potier L, Abi Khalil C, Capel E, Vigouroux C,
Caron-Debarle M, Capeau J, Marre M (2011) Type B insulin resistance syndrome associated
with an immune reconstitution inflammatory syndrome in an HIV-infected woman. J Clin
Endocrinol Metab 96 (4): E653-657
Mohammedi K, Maimaitiming S, Emery N, Bellili-Munoz N, Roussel R, Fumeron F, Hadjadj
S, Marre M, Velho G (2011) Allelic variations in superoxide dismutase-1 (SOD1) gene are
associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol Genet
Metab 104 (4): 654-660
Metzger R, Franke FE, Bohle RM, Alhenc-Gelas F, Danilov SM (2011) Heterogeneous
distribution of angiotensin I-converting enzyme (CD143) in the human and rat vascular
systems: vessel, organ and species specificity. Microvasc Res 81 (2): 206-215
McSwain NE, Champion HR, Fabian TC, Hoyt DB, Wade CE, Eastridge BJ, Proctor KG,
Rasmussen TE, Roussel RR, Butler FK, Holcomb JB, Schreiber MA, Shackford SR,
Blackbourne LH (2011) State of the art of fluid resuscitation 2010: prehospital and immediate
transition to the hospital. J Trauma 70 (5 Suppl): S2-10
Liu L, Lei T, Bankir L, Zhao D, Gai X, Zhao X, Yang B (2011) Erythrocyte permeability to
urea and water: comparative study in rodents, ruminants, carnivores, humans, and birds. J
Comp Physiol B 181 (1): 65-72
Lei T, Zhou L, Layton AT, Zhou H, Zhao X, Bankir L, Yang B (2011) Role of thin
descending limb urea transport in renal urea handling and the urine concentrating mechanism.
Am J Physiol Renal Physiol 301 (6): F1251-1259
Guerrot D, Hansel B, Perucca J, Roussel R, Bouby N, Girerd X, Bankir L (2011) Reduced
insulin secretion and nocturnal dipping of blood pressure are associated with a disturbed
circadian pattern of urine excretion in metabolic syndrome. J Clin Endocrinol Metab 96 (6):
E929-933
Gautier A, Roussel R, Lange C, Piguel X, Cauchi S, Vol S, Froguel P, Balkau B, Bonnet F
(2011) Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose
homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. Study.
Diabetes 60 (10): 2654-2663
Fumeron F, Lamri A, Abi Khalil C, Jaziri R, Porchay-Balderelli I, Lantieri O, Vol S, Balkau
B, Marre M, Data from the Epidemiological Study on the Insulin Resistance Syndrome Study
G (2011) Dairy consumption and the incidence of hyperglycemia and the metabolic
syndrome: results from a french prospective study, Data from the Epidemiological Study on
the Insulin Resistance Syndrome (DESIR). Diabetes Care 34 (4): 813-817
Fumeron F, Lamri A, Emery N, Bellili N, Jaziri R, Porchay-Baldérelli I, Lantieri O, Balkau
B, Marre M, and the D.E.S.I.R. Study Group (2011) Dairy products and the metabolic
syndrome in a prospective study, D.E.S.I.R. J Am Coll Nutr 30 (5 Suppl 1):454S–463S
Cheurfa N, Brenner GM, Reis AF, Dubois-Laforgue D, Roussel R, Tichet J, Lantieri O,
Balkau B, Fumeron F, Timsit J, Marre M, Velho G (2011) Decreased insulin secretion and
increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data
from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study.
Diabetologia 54 (3): 554-562
Bonnet F, Gauthier E, Gin H, Hadjadj S, Halimi JM, Hannedouche T, Rigalleau V, Romand
D, Roussel R, Zaoui P (2011) Expert consensus on management of diabetic patients with
impairment of renal function. Diabetes Metab 37 Suppl 2 S1-25
Blanchard A, Frank M, Wuerzner G, Peyrard S, Bankir L, Jeunemaitre X, Azizi M (2011)
Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.
Clin J Am Soc Nephrol 6 (4): 753-759
Alhenc-Gelas F, Bouby N, Richer C, Potier L, Roussel R, Marre M (2011) Kinins as
therapeutic agents in cardiovascular and renal diseases. Curr Pharm Des 17 (25): 2654-2662
Alessi MC, Nicaud V, Scroyen I, Lange C, Saut N, Fumeron F, Marre M, Lantieri O,
Fontaine-Bisson B, Juhan-Vague I, Balkau B, Tregouet DA, Morange PE, Group DS (2011)
Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of
metabolic syndrome and type 2 diabetes mellitus. Results from the D.E.S.I.R. prospective
cohort. Thromb Haemost 106 (3): 416-422
Abi Khalil C, Mohammedi K, Aubert R, Travert F, Hadjadj S, Roussel R, Fumeron F, Marre
M (2011) Intensifying glycaemic control with insulin reduces adiponectin and its HMW
isoform moderately in type 2, but not in type 1, diabetes. Diabetes Metab 37 (3): 259-261
Abi Khalil C, Mohammedi K, Aubert R, Abou Jaoude E, Travert F, Hadjadj S, Fumeron F,
Roussel R, Marre M (2011) Hyperadiponectinemia is independent of kidney function,
diabetes duration, and control in type 1 diabetic patients without microangiopathy. J Clin
Endocrinol Metab 96 (3): E485-487